EyePoint Pharmaceuticals
EYPT
#5227
Rank
S$1.91 B
Marketcap
S$23.12
Share price
0.45%
Change (1 day)
94.80%
Change (1 year)

EyePoint Pharmaceuticals (EYPT) - Cash on Hand

Cash on Hand as of September 2025 : S$0.26 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company has S$0.26 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

EyePoint Pharmaceuticals - Cash on Hand chart (from 2003 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31S$0.50 B15.31%
2023-12-31S$0.43 B125.6%
2022-12-31S$0.19 B-32.24%
2021-12-31S$0.28 B381.4%
2020-12-31S$59.41 M98.38%
2019-12-31S$29.94 M
2018-06-30S$52.84 M127.19%
2017-06-30S$23.26 M-40.44%
2016-06-30S$39.05 M1.58%
2015-06-30S$38.44 M68.73%
2014-06-30S$22.78 M74.8%
2013-06-30S$13.03 M-29.39%
2012-06-30S$18.46 M-37.65%
2011-06-30S$29.6 M21.4%
2010-06-30S$24.39 M144.75%
2009-06-30S$9.96 M-53.09%
2008-06-30S$21.24 M418.66%
2007-06-30S$4.09 M-77.56%
2006-06-30S$18.25 M10.12%
2005-06-30S$16.57 M-55.61%
2004-06-30S$37.34 M2582.85%
2003-06-30S$1.39 M
2001-06-30S$2.99 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NRC Health
NRC
S$2.87 M-98.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
S$0.17 M-99.94% Bahamas